Feeding the wrath with myelin
- PMID: 39341708
- PMCID: PMC11471388
- DOI: 10.1016/j.it.2024.09.004
Feeding the wrath with myelin
Abstract
Kloosterman and colleagues studied molecular and cellular changes during radiation therapy and disease recurrence across molecular subtypes of glioblastoma. They uncovered a distinct immune-cancer cell metabolic crosstalk during proneural/oligodendrocyte progenitor cell-like to mesenchymal-like transition, wherein macrophages feed on cholesterol-rich myelin debris to provide lipids to mesenchymal tumor cells, thereby fueling glioblastoma growth.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests C.V.R. is a member of the Trends in Immunology Advisory Board.
Similar articles
-
Lipid-Laden Macrophages Recycle Myelin to Feed Glioblastoma.Cancer Res. 2024 Nov 15;84(22):3712-3714. doi: 10.1158/0008-5472.CAN-24-3362. Cancer Res. 2024. PMID: 39292810 Free PMC article.
-
Macrophage-mediated myelin recycling fuels brain cancer malignancy.Cell. 2024 Sep 19;187(19):5336-5356.e30. doi: 10.1016/j.cell.2024.07.030. Epub 2024 Aug 12. Cell. 2024. PMID: 39137777 Free PMC article.
-
STAT3-controlled CHI3L1/SPP1 positive feedback loop demonstrates the spatial heterogeneity and immune characteristics of glioblastoma.Dev Cell. 2025 Jun 23;60(12):1751-1767.e9. doi: 10.1016/j.devcel.2025.01.014. Epub 2025 Feb 10. Dev Cell. 2025. PMID: 39933531
-
The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation.Med Res Rev. 2017 Mar;37(2):271-313. doi: 10.1002/med.21408. Epub 2016 Sep 12. Med Res Rev. 2017. PMID: 27617697
-
Rational therapeutic targeting of myeloid cells in glioblastoma: challenges and perspectives.Front Immunol. 2025 Jun 26;16:1472710. doi: 10.3389/fimmu.2025.1472710. eCollection 2025. Front Immunol. 2025. PMID: 40642066 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources